

The Psychedelic Podcast
Third Wave
The Psychedelic Podcast connects you to the leaders and pioneers of the psychedelic renaissance.
From deep healing to creativity, leadership to spirituality, business, health, human performance, relationships, sexuality, and even culture itself—every aspect of our world is being transformed by psychedelic medicines.
Get an inspired, informed, balanced look into how these powerful medicines are already being safely and responsibly used to catalyze both personal and collective transformation.
Whether you're just curious or a seasoned psychonaut, or somewhere in between, you'll get insightful, practical, cutting-edge conversations from the forefront of the psychedelic movement.
Join us as we explore how psychedelics can be integrated into culture for the evolution of humanity.
From deep healing to creativity, leadership to spirituality, business, health, human performance, relationships, sexuality, and even culture itself—every aspect of our world is being transformed by psychedelic medicines.
Get an inspired, informed, balanced look into how these powerful medicines are already being safely and responsibly used to catalyze both personal and collective transformation.
Whether you're just curious or a seasoned psychonaut, or somewhere in between, you'll get insightful, practical, cutting-edge conversations from the forefront of the psychedelic movement.
Join us as we explore how psychedelics can be integrated into culture for the evolution of humanity.
Episodes
Mentioned books

Nov 16, 2026 • 1h 20min
From Addiction to Devotion: Plant Medicine and Lasting Recovery - Luke Storey
Paul F. Austin and Luke Storey explore sobriety and psychedelics, a coca and nicotine habit, loneliness, and his new book, A Horse Named Lonesome. Find full show notes and links here: https://thethirdwave.co/podcast/episode-379/?ref=250 In this episode of The Psychedelic Podcast, Paul F. Austin welcomes back Luke Storey, host of The Life Stylist podcast and author of the new book A Horse Named Lonesome. Nearly 30 years sober, Luke shares how his first ayahuasca ceremonies reached what two decades of recovery work could not, and why he now approaches plant medicine far more selectively. Paul and Luke explore the coca and tobacco habit that carried him through writing the book, what quitting it taught him about dependence, and how a psilocybin ceremony revealed that only service could motivate the work. Their conversation also covers self-love, creating with integrity in a crowded media landscape, and why Luke sees separation as the root of loneliness and much of human suffering. Luke's new book, A Horse Named Lonesome, launches November 17, 2026. Pre-order now at ahorsenamedlonesome.com and get bonuses: access to his Inner Circle Book Club, an exclusive Lonesome Conversations six-part miniseries, and an ebook transcript of the series. Episode Links: A Horse Named Lonesome (pre-order with bonuses): http://ahorsenamedlonesome.com/ Luke Storey's website: https://lukestorey.com/ Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.

Nov 2, 2026 • 59min
Microdosing Ibogaine for Parkinson's: What One Case Study Found - Tobias Erny
Tobias Erny, a Swiss iboga practitioner and researcher, shares how ibogaine helped end his opiate addiction and led to decades of work with iboga. He explores a striking Parkinson’s case report, GDNF and dopamine neurons, differences between ibogaine and full-spectrum iboga, who may respond, medication interactions, cardiac safety, and plans for clinical trials.

Oct 20, 2026 • 38min
Daily Low-Dose Ketamine: Why Repetition May Matter More Than Intensity - Eiad Asbahi
In this episode of The Psychedelic Podcast, Paul F. Austin sits down with Eiad Asbahi, founder of Mindscape, a patient care coordination platform that connects people with licensed providers and pharmacies for low-dose ketamine care. Eiad spent 17 years running a hedge fund and reached the kind of success he had always dreamed about. Then his largest investment collapsed and his marriage ended, and he was forced to look inward. This epsiode is sponsored by Eiad Asbahi. Eiad describes the moment he realized he was the common denominator in his own failures. He talks about the core belief underneath it all, that he was "defective," and how Internal Family Systems therapy showed him there are no bad parts. He explains how building inner safety changed the way he parents his daughter, and why he uses ketamine to reconnect rather than to escape. Paul and Eiad also discuss the thinking behind Mindscape's daily low-dose model and the case for repetition over peak experiences. The conversation ends with a candid disagreement about dependence, personal agency, clinical oversight, and what responsible access to ketamine should look like. Eiad Asbahi is a founder and father. He spent 17 years running a hedge fund and reached the highest levels of professional success before a long professional collapse. Around the same time, a divorce sent him inward. He wanted to model a secure relationship for his daughter, so he began Internal Family Systems therapy and spent the next five years rebuilding his relationship with himself. Eiad founded Mindscape to make the kind of guided, medically supervised care that changed his life easier to find and navigate. Mindscape is a patient care coordination platform that connects people with independently licensed providers and pharmacies, and its approach is built on repetition over intensity. Today his work centers on what comes after healing: deliberately rebuilding identity, motivation, and meaning. Highlights: From hedge fund highs to a five-year professional collapse Realizing he was the common denominator in his failures The core belief beneath it all: feeling defective Internal Family Systems and the idea that there are no bad parts How repeated inner work builds inner safety Becoming the protector for his daughter that he never had How Mindscape's stripped-down model differs from other ketamine platforms Daily low-dose ketamine: repetition over intensity, connection over escape Eiad's self-care practices: movement, music, and red light Dependence, agency, and accountability: where Paul and Eiad disagree Episode Links: Mindscape: https://themindscape.com/ Mindscape on Instagram: https://www.instagram.com/themindscape.official Eiad on Instagram: https://www.instagram.com/eiadasbahi

Oct 5, 2026 • 1h 6min
Why 5-MeO-DMT Doesn't Have to Be Explosive - Mira Funk, LCSW
Mira Funk, a Harvard-educated queer, nonbinary psychotherapist and founder of Unjourneying, explores presence-centered psychedelic practice. She discusses how Zen and mushrooms shaped her path, extended-release 5-MeO-DMT routes including rectal and vaginal administration, pelvic trauma, somatic support, DIY safety, and gentler salvia work using precise titration.

Sep 25, 2026 • 29min
Why Medicalizing Psychedelics Is a Mistake - Dave Asprey
Dave Asprey, entrepreneur, author, biohacking pioneer, and Bulletproof Coffee founder, returns for a wide-ranging conversation on psychedelics and human potential. They explore the Beyond Wonderland conference, consciousness beyond psychedelics, the CIA’s role in psychedelic history, medicalization, microdosing regulation, and the future of research into altered states and latent abilities.

Sep 23, 2026 • 1h 10min
Psychedelics, AI, and the Right to Think - Ramez Naam
Ramez Naam, computer scientist, climate investor, and award-winning author, explores how psychedelics shaped his neuroscience work and Nexus trilogy. He discusses brain-computer interfaces, psilocybin and 5-MeO-DMT in mental healthcare, and the case for cognitive liberty. The conversation also ventures into clean energy, geoengineering, AI as a private thought partner, and protecting freedom of thought.

Sep 14, 2026 • 55min
Psychedelic Therapy Needs More Than Good Intentions - Kylea Taylor, M.S., LMFT
Kylea Taylor, M.S., LMFT, is a therapist, Holotropic Breathwork facilitator, and founder of InnerEthics®. She explores why altered states intensify intimacy, power dynamics, and practitioner blind spots. Topics include personal experience, touch and consent, transference, trusting inner healing intelligence, ethical drift, and compassionate peer consultation.

Sep 7, 2026 • 1h 4min
Iboga Initiation and the Wisdom of Discomfort - Paije Alexandra West
Paije Alexandra West, founder of ETÉREO and a twice-initiated Bwiti practitioner, explores iboga beyond the clinical lens. She discusses initiation as a demanding rite of passage, the differences between root bark and total alkaloid extract, and the role of Bwiti music. They also examine cardiac screening, addiction support, community, discomfort, and the long road of integration.

Aug 31, 2026 • 60min
SSRI Tapering and Psychedelic Readiness - Dr. Josef Witt-Doerring
In this episode of The Psychedelic Podcast, Paul F. Austin speaks with psychiatrist and TaperClinic founder Dr. Josef Witt-Doerring about antidepressant withdrawal, psychiatric deprescribing, and psychedelic readiness. Find full show notes and links here: https://thethirdwave.co/podcast/episode-371/?ref=278 Josef explains what he learned reviewing drug safety at the FDA, why withdrawal can be mistaken for relapse, and how tapering often becomes more difficult at lower doses. They also explore the lifestyle foundations of mental health, benzodiazepine withdrawal, and why psychedelic clinics may need far more sophisticated support as increasingly medicated patients seek psilocybin, MDMA, LSD, and ketamine. Dr. Josef Witt-Doerring, MD, is a psychiatrist renowned for his expertise in drug tapering and withdrawal management. With years of experience in clinical psychiatry, he has developed a particular interest and specialization in assisting patients with the safe and effective tapering of psychiatric medications. His approach is patient-centered, focusing on individualized plans that prioritize patient well-being and functioning. He is the founder and medical director of TaperClinic. Highlights: What antidepressant research leaves unanswered Why withdrawal can resemble relapse How lower doses change tapering Five foundations before optimization hacks Benzodiazepines in psychiatric deprescribing Psychedelics versus conventional drug models Insurance pressure on psychedelic clinics Preparing for heavily medicated patients TaperClinic: https://taperclinic.com/ TaperClinic Free Guide: https://taperclinic.com/free-guide/ SSRI Deprescribing & Psychedelic Readiness Training with Dr. Dave Rabin: https://edu.psychedeliccoaching.institute/ssri-deprescribing-and-psychedelic-readiness-certification/?ref=12 Disclaimer: This content is for educational, informational, and entertainment purposes only. We do not promote or encourage the illegal use of any controlled substances. Nothing said here is medical or legal advice. Always consult a qualified medical or mental health professional before making decisions related to your health. The views expressed herein belong to the speaker alone, and do not reflect the views of any other person, company, or organization.

Aug 24, 2026 • 1h 9min
SSRIs, Psychedelics, & Rethinking Mental Health Treatment - Robert Whitaker
Robert Whitaker, investigative journalist and author of Anatomy of an Epidemic, critiques modern psychiatric practice. He traces how the chemical imbalance story took hold, explores long-term outcomes of antidepressant use, and examines SSRI withdrawal versus recurrence. He warns about psychedelic medicalization and highlights the importance of ritual, community, and preserving personal agency in mental health care.


